Impact of Alexithymia on the Lipid Profile in Major Depressed Individuals.


Journal

Journal of lipids
ISSN: 2090-3030
Titre abrégé: J Lipids
Pays: Egypt
ID NLM: 101553819

Informations de publication

Date de publication:
2022
Historique:
received: 26 01 2022
accepted: 29 05 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

The cooccurrence of major depression and dyslipidaemia is associated with negative cardiovascular outcome, which seems to justify a better identification of the factors favouring the development of dyslipidaemia in major depressed individuals. In the literature, there are arguments in favour of a special relationship between dyslipidaemia and alexithymia. However, despite a high prevalence of alexithymia in major depressed individuals, no study has investigated the impact of this personality trait on the lipid profile in this particular subpopulation. Given these elements, the aim of this study was therefore to investigate the risk of dyslipidaemia associated with alexithymia in major depressed individuals to allow better cardiovascular prevention in this subpopulation. The prevalence of dyslipidaemia was 43.8% in our sample of major depressed individuals. After adjusting for the main confounding factors, multivariate logistic regression analyses demonstrated that alexithymia was a risk factor for dyslipidaemia in major depressed individuals. In this study, we found that alexithymia is a risk factor for dyslipidaemia in major depressed individuals, which seems to justify better identification and adequate management of this personality trait in order to allow a better lipid profile in this subpopulation at high cardiovascular risk.

Sections du résumé

Background UNASSIGNED
The cooccurrence of major depression and dyslipidaemia is associated with negative cardiovascular outcome, which seems to justify a better identification of the factors favouring the development of dyslipidaemia in major depressed individuals. In the literature, there are arguments in favour of a special relationship between dyslipidaemia and alexithymia. However, despite a high prevalence of alexithymia in major depressed individuals, no study has investigated the impact of this personality trait on the lipid profile in this particular subpopulation. Given these elements, the aim of this study was therefore to investigate the risk of dyslipidaemia associated with alexithymia in major depressed individuals to allow better cardiovascular prevention in this subpopulation.
Results UNASSIGNED
The prevalence of dyslipidaemia was 43.8% in our sample of major depressed individuals. After adjusting for the main confounding factors, multivariate logistic regression analyses demonstrated that alexithymia was a risk factor for dyslipidaemia in major depressed individuals.
Conclusions UNASSIGNED
In this study, we found that alexithymia is a risk factor for dyslipidaemia in major depressed individuals, which seems to justify better identification and adequate management of this personality trait in order to allow a better lipid profile in this subpopulation at high cardiovascular risk.

Identifiants

pubmed: 35755481
doi: 10.1155/2022/5450814
pmc: PMC9225907
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5450814

Informations de copyright

Copyright © 2022 Camille Point et al.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest with the work carried out in this study.

Références

Psychopathology. 2012;45(1):22-8
pubmed: 22123513
Diabetes Metab J. 2020 Apr;44(2):307-315
pubmed: 31701694
Open Forum Infect Dis. 2019 Jul 27;6(9):ofz331
pubmed: 31660407
J Diabetes Metab Disord. 2019 Jun 07;18(1):191-198
pubmed: 31275890
Braz J Psychiatry. 2014 Apr-Jun;36(2):125-30
pubmed: 24554275
Eat Weight Disord. 2021 Aug;26(6):1813-1823
pubmed: 32920774
Front Psychol. 2020 Aug 28;11:2026
pubmed: 32982843
Scand J Psychol. 2017 Aug;58(4):318-323
pubmed: 28636271
Clin Exp Hypertens. 2019;41(6):538-547
pubmed: 30303409
Ann Intern Med. 2017 Dec 5;167(11):ITC81-ITC96
pubmed: 29204622
Evid Based Ment Health. 2019 Feb;22(1):36-43
pubmed: 30077988
Health Psychol. 2021 Feb;40(2):113-124
pubmed: 33252963
J Psychosom Res. 2010 Feb;68(2):139-47
pubmed: 20105696
Front Psychiatry. 2020 Jan 31;10:1026
pubmed: 32082200
Psychosomatics. 2007 May-Jun;48(3):239-46
pubmed: 17478593
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1982-6
pubmed: 18940224
Diabetes Ther. 2016 Jun;7(2):203-19
pubmed: 27056202
Physiol Behav. 2020 Dec 1;227:113151
pubmed: 32841673
Curr Hypertens Rev. 2014 Jul 01;:
pubmed: 24993281
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Int J Psychophysiol. 2019 Dec;146:180-189
pubmed: 31639379
Crit Care. 2011 Apr 20;15(2):221
pubmed: 21586104
Psychiatry Res. 2016 Feb 28;236:58-63
pubmed: 26747214
Harv Rev Psychiatry. 2014 May-Jun;22(3):162-78
pubmed: 24736520
Psychiatry Res. 2014 Feb 28;215(2):438-43
pubmed: 24388726
Eur J Prev Cardiol. 2017 Jan;24(2):145-152
pubmed: 27671771
Clin Chim Acta. 2018 Dec;487:117-125
pubmed: 30201369
J Affect Disord. 2018 Oct 1;238:101-110
pubmed: 29870819
Psychosomatics. 2001 May-Jun;42(3):229-34
pubmed: 11351111
Eur Eat Disord Rev. 2019 Nov;27(6):628-640
pubmed: 31264316
J Clin Psychol. 2017 Jan;73(1):76-87
pubmed: 27129142
Front Psychol. 2018 Aug 29;9:1614
pubmed: 30210420
Early Interv Psychiatry. 2020 Jun;14(3):336-342
pubmed: 31402575
Psychiatry Res. 2017 Aug;254:75-79
pubmed: 28456025
J Psychiatr Res. 2018 Jul;102:23-28
pubmed: 29567524
Sleep. 2005 Apr;28(4):499-521
pubmed: 16171294
J Psychosom Res. 2010 Mar;68(3):269-73
pubmed: 20159212
Can J Cardiol. 2015 May;31(5):605-12
pubmed: 25816728
Neuroimmunomodulation. 2014;21(5):234-9
pubmed: 24603661
J Psychosom Res. 1999 Dec;47(6):635-45
pubmed: 10661609
Exp Clin Cardiol. 2013 Winter;18(1):10-2
pubmed: 24294029
J Psychiatr Res. 2022 Jun;150:338-345
pubmed: 34838265
Psychiatry Res. 2018 May;263:88-93
pubmed: 29510344
Psychother Psychosom. 2000 Nov-Dec;69(6):303-8
pubmed: 11070442
Percept Mot Skills. 1997 Dec;85(3 Pt 1):1018
pubmed: 9399312
Psychiatry Res. 2011 Dec 30;190(2-3):232-9
pubmed: 21683455
Psychosomatics. 2018 Mar - Apr;59(2):144-157
pubmed: 29246639

Auteurs

Camille Point (C)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Benjamin Wacquier (B)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Marjorie Dosogne (M)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Mohammed Al Faker (M)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Hadrien Willame (H)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Gwenolé Loas (G)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Matthieu Hein (M)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Classifications MeSH